Literature DB >> 15997423

Osteoporosis in HFE2 juvenile hemochromatosis. A case report and review of the literature.

Nicholas G Angelopoulos1, Anastasia K Goula, George Papanikolaou, George Tolis.   

Abstract

Juvenile hemochromatosis (JH) is a severe form of hemochromatosis, which involves rapid iron overload and leads to organ damage, typically before the age of 30. We report a single case of a 25-year-old man suffering from juvenile hemochromatosis, with aggressive clinical manifestations, typically characterized by transaminasemia and progressive erectile dysfunction, due to hypogonadotropic hypogonadism. The clinical case appears interesting, as the patient also had secondary osteoporosis accompanied by increased bone resorption, which prevalently affected trabecular bone. Approximately 6 months after normalization of serum ferritin levels was achieved by frequent phlebotomies, he became eugonadal and bone mineral density of the lumbar spine increased. Our observations suggest that osteoporosis might occur in the state of JH even at a young age, mainly due to the deprivation of sex steroids and the direct tissue toxicity of iron.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15997423     DOI: 10.1007/s00198-005-1920-6

Source DB:  PubMed          Journal:  Osteoporos Int        ISSN: 0937-941X            Impact factor:   4.507


  26 in total

1.  Transfusional hemochromatosis: quantitative relation of MR imaging pituitary signal intensity reduction to hypogonadotropic hypogonadism.

Authors:  G Sparacia; A Iaia; A Banco; P D'Angelo; R Lagalla
Journal:  Radiology       Date:  2000-06       Impact factor: 11.105

2.  The effects of plasma estradiol levels on increases in vertebral and femoral bone density following therapy with estradiol and estradiol with testosterone implants.

Authors:  T Garnett; J Studd; N Watson; M Savvas; A Leather
Journal:  Obstet Gynecol       Date:  1992-06       Impact factor: 7.661

3.  Juvenile genetic hemochromatosis is clinically and genetically distinct from the classical HLA-related disorder.

Authors:  M Cazzola; P Cerani; A Rovati; A Iannone; G Claudiani; G Bergamaschi
Journal:  Blood       Date:  1998-10-15       Impact factor: 22.113

4.  Spontaneous multiple vertebral fractures revealed primary haemochromatosis.

Authors:  M Duquenne; V Rohmer; E Legrand; D Chappard; N Wion Barbot; M F Basle; M Audran; J C Bigorgne
Journal:  Osteoporos Int       Date:  1996       Impact factor: 4.507

5.  HFE genotype in patients with hemochromatosis and other liver diseases.

Authors:  B R Bacon; J K Olynyk; E M Brunt; R S Britton; R K Wolff
Journal:  Ann Intern Med       Date:  1999-06-15       Impact factor: 25.391

6.  Bone involvement in primary hemochromatosis and alcoholic cirrhosis.

Authors:  D Conte; M P Caraceni; J Duriez; C Mandelli; E Corghi; M Cesana; S Ortolani; P A Bianchi
Journal:  Am J Gastroenterol       Date:  1989-10       Impact factor: 10.864

7.  Juvenile idiopathic haemochromatosis: a life-threatening disorder presenting as hypogonadotropic hypogonadism.

Authors:  M Cazzola; E Ascari; G Barosi; G Claudiani; M Daccó; J P Kaltwasser; N Panaiotopoulos; K P Schalk; E E Werner
Journal:  Hum Genet       Date:  1983       Impact factor: 4.132

8.  Low serum 25-hydroxyvitamin D in hereditary hemochromatosis: relation to iron status.

Authors:  L H Chow; J V Frei; A B Hodsman; L S Valberg
Journal:  Gastroenterology       Date:  1985-04       Impact factor: 22.682

9.  Idiopathic hemochromatosis in a young female. A case study and review of the syndrome in young people.

Authors:  J M Lamon; S P Marynick; R Roseblatt; S Donnelly
Journal:  Gastroenterology       Date:  1979-01       Impact factor: 22.682

10.  Longitudinal association between sex hormone levels, bone loss, and bone turnover in elderly men.

Authors:  Luigi Gennari; Daniela Merlotti; Giuseppe Martini; Stefano Gonnelli; Beatrice Franci; Stella Campagna; Barbara Lucani; Norberto Dal Canto; Roberto Valenti; Carlo Gennari; Ranuccio Nuti
Journal:  J Clin Endocrinol Metab       Date:  2003-11       Impact factor: 5.958

View more
  15 in total

1.  Bone status in a mouse model of genetic hemochromatosis.

Authors:  P Guggenbuhl; P Fergelot; M Doyard; H Libouban; M-P Roth; Y Gallois; G Chalès; O Loréal; D Chappard
Journal:  Osteoporos Int       Date:  2010-10-26       Impact factor: 4.507

Review 2.  Impact of bone disease and pain in thalassemia.

Authors:  Antonio Piga
Journal:  Hematology Am Soc Hematol Educ Program       Date:  2017-12-08

3.  Hepatic magnetic resonance imaging with T2* mapping of ovariectomized rats: correlation between iron overload and postmenopausal osteoporosis.

Authors:  Lingshan Chen; Zhengqiu Zhu; Xingui Peng; Yuancheng Wang; Yaling Wang; Min Chen; Qi Wang; Jiyang Jin
Journal:  Eur Radiol       Date:  2014-04-28       Impact factor: 5.315

4.  Association between iron overload and osteoporosis in patients with hereditary hemochromatosis.

Authors:  L Valenti; M Varenna; A L Fracanzani; V Rossi; S Fargion; L Sinigaglia
Journal:  Osteoporos Int       Date:  2008-07-26       Impact factor: 4.507

Review 5.  Endocrine dysfunction in hereditary hemochromatosis.

Authors:  C Pelusi; D I Gasparini; N Bianchi; R Pasquali
Journal:  J Endocrinol Invest       Date:  2016-03-07       Impact factor: 4.256

6.  [Metabolic bone diseases].

Authors:  F Jakob
Journal:  Internist (Berl)       Date:  2007-10       Impact factor: 0.743

7.  Iron and menopause: does increased iron affect the health of postmenopausal women?

Authors:  Jinlong Jian; Edward Pelle; Xi Huang
Journal:  Antioxid Redox Signal       Date:  2009-12       Impact factor: 8.401

8.  A late presentation of a fatal disease: juvenile hemochromatosis.

Authors:  Cynthia Cherfane; Pauline Lee; Leana Guerin; Kyle Brown
Journal:  Case Rep Med       Date:  2013-09-11

9.  A Rare Presentation of Transfusional Hemochromatosis: Hypogonadotropic Hypogonadism.

Authors:  Rifki Ucler; Erdal Kara; Murat Atmaca; Sehmus Olmez; Murat Alay; Yaren Dirik; Aydin Bora
Journal:  Case Rep Endocrinol       Date:  2015-07-21

10.  Association between serum ferritin and osteocalcin as a potential mechanism explaining the iron-induced insulin resistance.

Authors:  Martí Juanola-Falgarona; José Cándido-Fernández; Jordi Salas-Salvadó; Miguel A Martínez-González; Ramón Estruch; Miquel Fiol; Victoria Arija-Val
Journal:  PLoS One       Date:  2013-10-22       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.